Optum Ventures is among the investors in a $11.1 million series A investment for Risa Labs, which is developing an AI operating system for oncology.
The venture capital arm of the UnitedHealth Group subsidiary co-led the funding round with Cencora Ventures, part of pharma company Cencora.
Risa Labs said the funding will accelerate the deployment of its platform at health systems, cancer clinics, specialty pharmacies and infusion networks across the U.S., according to a Jan. 13 news release. The startup aims to reduce administrative tasks, cut denials and speed up prior authorizations with AI.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.